INTEGRATED SAFETY OF LESINURAD, A NOVEL URIC ACID REABSORPTION INHIBITOR FOR THE TREATMENT OF GOUT

被引：0
|
作者：
Becker, M. A. [1 ]
Keenan, R. T. [2 ]
Khanna, P. P. [3 ]
Malamet, R. [4 ]
Bos, K. [4 ]
Li, J. [4 ]
Hu, J. [5 ]
White, W. B. [6 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] AstraZeneca, Wilmington, DE USA
[5] Formerly Ardea Biosci Inc, San Diego, CA USA
[6] Univ Connecticut, Sch Med, Farmington, CT USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3674
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0444
引用
收藏
页码：375 / 376
页数：2
相关论文
共 50 条
  • [1] Integrated Safety of Lesinurad, a Novel Uric Acid Reabsorption Inhibitor for the Treatment of Gout
    Becker, Michael A.
    Keenan, Robert T.
    Khanna, Puja
    Malamet, Raymond
    Bos, Kathleen
    Li, Jingyi
    Hu, Jia
    White, William
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
    Terkeltaub, Robert
    Saag, Kenneth G.
    Goldfarb, David S.
    Baumgartner, Scott
    Schechter, Bruce M.
    Valiyil, Ritu
    Jalal, Diana
    Pillinger, Michael
    White, William B.
    RHEUMATOLOGY, 2019, 58 (01) : 61 - 69
  • [3] Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout
    Dalbeth, Nicola
    Jones, Graeme
    Terkeltaub, Robert
    Khanna, Dinesh
    Kopicko, Jeff
    Bhakta, Nihar
    Fung, Maple
    Storgard, Chris
    Baumgartner, Scott
    Perez-Ruiz, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans
    Shah, Vishal
    Yang, Chun
    Shen, Zancong
    Kerr, Bradley M.
    Tieu, Kathy
    Wilson, David M.
    Hall, Jesse
    Gillen, Michael
    Lee, Caroline A.
    XENOBIOTICA, 2019, 49 (07) : 811 - 822
  • [5] Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males
    Shen, Zancong
    Rowlings, Colin
    Kerr, Brad
    Hingorani, Vijay
    Manhard, Kimberly
    Quart, Barry
    Yeh, Li-Tain
    Storgard, Chris
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3423 - 3434
  • [6] LESINURAD, A NOVEL SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN COMBINATION WITH FEBUXOSTAT, IN PATIENTS WITH TOPHACEOUS GOUT: THE CRYSTAL PHASE III CLINICAL TRIAL
    Dalbeth, N.
    Jones, G.
    Terkeltaub, R.
    Khanna, D.
    Kopicko, J.
    Bhakta, N.
    Fung, M.
    Storgard, C.
    Baumgartner, S.
    Perez-Ruiz, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 778 - 778
  • [7] Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout Findings of a Phase III Clinical Trial
    Dalbeth, Nicola
    Jones, Graeme
    Terkeltaub, Robert
    Khanna, Dinesh
    Kopicko, Jeff
    Bhakta, Nihar
    Adler, Scott
    Fung, Maple
    Storgard, Chris
    Baumgartner, Scott
    Perez-Ruiz, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 (09) : 1903 - 1913
  • [8] EXAMINATION OF SERUM URIC ACID (SUA) LOWERING AND SAFETY WITH EXTENDED TREATMENT WITH LESINURAD AND ALLOPURINOL IN SUBJECTS WITH GOUT
    Saag, K. G.
    Becker, M. A.
    Storgard, C.
    Fung, M.
    Bhakta, N.
    Adler, S.
    Hu, J.
    Bardin, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 371 - 371
  • [9] Examination of Serum Uric Acid (sUA) Lowering and Safety with Extended Lesinurad plus Allopurinol Treatment in Subjects with Gout
    Saag, Kenneth
    Becker, Michael A.
    Storgard, Chris
    Fung, Maple
    Hu, Jia
    Bardin, Thomas
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Development of selective uric acid reabsorption inhibitors (SURIs) for the treatment of gout
    Girardet, Jean-Luc
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
12345